IL1B and COVID-19: Other proinflammatory cytokines or receptor inhibitors, including IL-1 and IL-6 receptor inhibitor, showed significant benefit of survival in patients with COVID-19.22,252 The IL-1 inhibitor anakinra is a recombinant human IL-1 receptor antagonist.